Comments
Pharmaceutical company, Austrak Private Limited, has launched its new super specialty division to focus on nephrology and urology.
“This division will focus on around 73 valued products in the segment. Our aim is to develop and market high quality specialty, therapeutic and medical products to cure critical diseases like Chronic Kidney Disease (CKD) and Urology related ailments with their high prevalence, morbidity and mortality and ease sufferings,’‘ Vittal, Chairman, Austrak, told newspersons at a press conference here on Wednesday.
Large numbers of patients below the poverty line, low gross domestic product, and low monetary allocations for health care have led to suboptimal outcomes,’‘ he said.
“Moreover, CKD, urinary problems and other non-communicable diseases have often been ignored in the face of persistent challenges due to competition for resources of communicable diseases and high infant and maternal mortality,” he added.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.